24 May 2013
Keywords: epo, revokes, osi, dpp-4, patent, pharmaceuticals, says
Article | 21 April 2008
OSI Pharmaceuticals says that the European Patent Office has revoked one of its dipeptidyl peptidase-4 patents, EP0896538, claiming the use ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
21 April 2008
23 May 2013
© 2013 thepharmaletter.com